GlassScriptPhysician profile
Michael Scot Dee
NPI 1710106653
$2,912.21
in general payments reported to CMS, 2019-2025
38 companies · $548 in 2025
The $548 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2020: $126 · 2021: $60.51 · 2022: $316 · 2023: $321 · 2024: $668 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,247 · Travel and Lodging: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,247.13 |
| Travel and Lodging | $290.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Active Medical, LLC | $721.18 | 2019-2024 | |
| Stryker Corporation | $462.00 | 2019-2025 | Salvation, Gamma, Iconix |
| Smith+Nephew, INC. | $228.62 | 2019-2025 | Multifix, Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Pacira Pharmaceuticals Incorporated | $189.25 | 2023-2025 | Iovera, Zilretta, Exparel |
| Depuy Synthes Sales INC. | $168.28 | 2021-2025 | Monovisc, Orthovisc, Microfix Quickanchor Ethibond |
| Zimmer Biomet Holdings, INC. | $157.54 | 2022-2025 | Persona, Tapestry |
| Vericel Corporation | $129.11 | 2019-2025 | Maci |
| Anika Therapeutics, INC. | $111.23 | 2022-2025 | Wristmotion, Integrity, Total Anika |
| Solventum Corporation | $74.41 | 2024-2025 | Prevena |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.86 | 2020-2023 | Synjardy, Jardiance, Tradjenta |
| Nevro Corp. | $53.03 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $41.98 | 2025 | |
| Amgen INC. | $35.04 | 2019 | |
| Corcept Therapeutics | $31.44 | 2022 | |
| Abbvie INC. | $29.76 | 2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $27.58 | 2020-2021 | |
| Moximed, INC | $27.22 | 2025 | Misha Knee System, Small, Left |
| Bioventus LLC | $26.67 | 2023-2024 | Durolane, Durolane |
| Takeda Pharmaceuticals U.S.A., INC. | $25.32 | 2020-2024 | Trintellix |
| Alafair Biosciences, INC. | $23.82 | 2025 | Versawrap |
| Endo Pharmaceuticals INC. | $23.62 | 2022 | |
| Globus Medical, INC. | $21.79 | 2023 | Ankle Fracture System |
| International Rehabilitative Sciences, INC | $21.77 | 2024 | Rs 4i Plus Sequential Stimulator |
| Sanofi-Aventis U.S. LLC | $20.15 | 2024 | |
| Nalu Medical, INC. | $18.64 | 2022 | |
| Seqirus USA INC | $17.28 | 2025 | Fluad, Flucelvax |
| Exact Sciences Corporation | $16.96 | 2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $15.89 | 2024 | |
| Si-Bone, INC. | $15.64 | 2022 | |
| Davol INC. | $14.94 | 2024 | Arista Ah Flexitip |
| Orthofix Medical, INC. | $14.47 | 2023 | Physio-Stim |
| Pfizer INC. | $14.34 | 2023 | |
| Idorsia Pharmaceuticals US INC | $14.26 | 2023 | Quviviq |
| Medtronic, INC. | $13.67 | 2025 | Aquamantys(Tm) |
| Astrazeneca Pharmaceuticals LP | $13.31 | 2019 | |
| Dynavax Technologies Corporation | $12.65 | 2022 | |
| Abbott Laboratories | $12.43 | 2019 | |
| Genentech USA, INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.